Zylox-Tonbridge Medical Technology (02190) Announces Share Repurchase and New Share Issuance

Bulletin Express11-07

Zylox-Tonbridge Medical Technology Co., Ltd. (02190) disclosed changes to its share capital as of 07 November 2025. A total of 50,000 H shares (approximately 0.0155% of its previously issued shares) were repurchased at a highest price of HKD 23.64 and a lowest price of HKD 23.20, with an aggregate payment of HKD 1,171,660. These repurchased shares are held as treasury shares, increasing the treasury share count to 6,846,131.

The company also issued 7,270,000 new shares to a director and 6,680,000 new shares to other participants under its 2025 Share Incentive Scheme at RMB 1 per share. Following these changes, the total number of issued shares (excluding treasury shares) rose from 315,604,613 to 329,504,613, and inclusive of treasury shares the closing balance stands at 336,350,744.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1129205500?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-07 22:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1129205500","market":"us","top_or_hot":-1,"title":"Zylox-Tonbridge Medical Technology (02190) Announces Share Repurchase and New Share Issuance","media":"Bulletin Express","content":"<p>Zylox-Tonbridge Medical Technology Co., Ltd. (02190) disclosed changes to its share capital as of 07 November 2025. A total of 50,000 H shares (approximately 0.0155% of its previously issued shares) were repurchased at a highest price of HKD 23.64 and a lowest price of HKD 23.20, with an aggregate payment of HKD 1,171,660. These repurchased shares are held as treasury shares, increasing the treasury share count to 6,846,131.</p>\n<p>The company also issued 7,270,000 new shares to a director and 6,680,000 new shares to other participants under its 2025 Share Incentive Scheme at RMB 1 per share. Following these changes, the total number of issued shares (excluding treasury shares) rose from 315,604,613 to 329,504,613, and inclusive of treasury shares the closing balance stands at 336,350,744.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zylox-Tonbridge Medical Technology (02190) Announces Share Repurchase and New Share Issuance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZylox-Tonbridge Medical Technology (02190) Announces Share Repurchase and New Share Issuance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-07 22:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zylox-Tonbridge Medical Technology Co., Ltd. (02190) disclosed changes to its share capital as of 07 November 2025. A total of 50,000 H shares (approximately 0.0155% of its previously issued shares) were repurchased at a highest price of HKD 23.64 and a lowest price of HKD 23.20, with an aggregate payment of HKD 1,171,660. These repurchased shares are held as treasury shares, increasing the treasury share count to 6,846,131.</p>\n<p>The company also issued 7,270,000 new shares to a director and 6,680,000 new shares to other participants under its 2025 Share Incentive Scheme at RMB 1 per share. Following these changes, the total number of issued shares (excluding treasury shares) rose from 315,604,613 to 329,504,613, and inclusive of treasury shares the closing balance stands at 336,350,744.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02190","symbol_name":"归创通桥","start_time":0,"source_url":"","article_id":"1129205500","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1129205500","pubTimestamp":1762524108,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Zylox-Tonbridge Medical Technology Co., Ltd. (02190) disclosed changes to its share capital as of 07 November 2025. A total of 50,000 H shares (approximately 0.0155% of its previously issued shares)...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02190":"归创通桥"},"translate_title":"归乐通桥医疗科技(02190)公布购回股份及发行新股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02190":1},"content_text":"Zylox-Tonbridge Medical Technology Co., Ltd. (02190) disclosed changes to its share capital as of 07 November 2025. A total of 50,000 H shares (approximately 0.0155% of its previously issued shares) were repurchased at a highest price of HKD 23.64 and a lowest price of HKD 23.20, with an aggregate payment of HKD 1,171,660. These repurchased shares are held as treasury shares, increasing the treasury share count to 6,846,131.\nThe company also issued 7,270,000 new shares to a director and 6,680,000 new shares to other participants under its 2025 Share Incentive Scheme at RMB 1 per share. Following these changes, the total number of issued shares (excluding treasury shares) rose from 315,604,613 to 329,504,613, and inclusive of treasury shares the closing balance stands at 336,350,744.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1129205500","isCrawlerRequest":true}